Literature DB >> 19519616

Persistent subcutaneous nodules after immunotherapy injections for allergic asthma.

Müge G Ozden1, Mehmet Kefeli, Fatma Aydin, Nilgün Senturk, Tayyar Canturk, Ahmet Y Turanli.   

Abstract

Adverse effects of desensitization injections mostly consist of local transient reactions. Rarely, persistent subcutaneous nodular lesions may also develop at the site of injection. These reactions have been attributed to the vaccines containing aluminium hydroxide. Aluminium hydroxide is used as an adjuvant in vaccines and hyposensitization solutions. We describe a patient who presented persistent, itchy subcutaneous nodules as a local reaction to allergen immunotherapy for the treatment of allergic asthma. (c) 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519616     DOI: 10.1111/j.1600-0560.2008.01152.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Long-term clinical course and prognosis of vaccine-related persistent itching nodules (1997-2019): An observational study.

Authors:  Anette Gente Lidholm; Annica Inerot; Martin Gillstedt; Elisabet Bergfors; Birger Trollfors
Journal:  Vaccine X       Date:  2022-04-29

2.  Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.

Authors:  Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2014-01-20       Impact factor: 3.406

3.  The size of micro-crystalline tyrosine (MCT®) influences its recognition and uptake by THP-1 macrophages in vitro.

Authors:  Emma Shardlow; Christopher Exley
Journal:  RSC Adv       Date:  2019-08-07       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.